Antiperspirant Deodorant Recalled Nationwide for Manufacturing Compliance Deviations
A.P. Deauville is recalling Power Stick for Her Roll-On Antiperspirant Deodorant nationwide due to manufacturing compliance deviations. The recall affects 21,265 cases distributed across the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary, firm-initiated recall for manufacturing compliance deviations with no reported illnesses or injuries, matching the rubric criteria for Moderate severity.
Plain-English summary
A.P. Deauville, LLC is recalling Power Stick for Her Roll-On Antiperspirant Deodorant, Powder Fresh scent, in 1.8 oz / 53 mL units distributed nationwide. The recall affects 21,265 cases and was initiated on July 10, 2025.
The FDA has classified this as a Class II recall due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. Affected lot numbers are 032026B011, 032226B031, 051626C241, 061526C882, 071226D371, 071226D381, 082526E341, and 082826E402.
The recalling firm, A.P. Deauville, LLC, is located in Easton, Pennsylvania. This is an ongoing voluntary recall initiated by the firm.
The recalled product
- Product
- POWER STICK FOR HER ROLL- ON ANTIPERSPIRANT DEODORANT POWDER FRESH (ALUMINUM SESQUICHLOROHYDRATE)
- Brand
- POWER STICK FOR HER ROLL- ON ANTIPERSPIRANT DEODORANT POWDER FRESH
- Manufacturer
- A.P. Deauville, LLC
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot # 032026B011
- 032226B031
- 051626C241
- 061526C882
- 071226D371
- 071226D381
- 082526E341
- 082826E402
UPCs (2)
- 0815195019313
- 815195019313
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27